PET imaging of COVID-19: the target and the number
Eur J Nucl Med Mol Imaging
.
2020 Jul;47(7):1636-1637.
doi: 10.1007/s00259-020-04820-z.
Epub 2020 Apr 17.
Authors
E Guedj
1
2
3
,
A Verger
4
5
,
S Cammilleri
6
7
8
Affiliations
1
Aix-Marseille Université, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France. eric.guedj@ap-hm.fr.
2
Department of Nuclear Medicine, Assistance Publique des Hôpitaux de Marseille, Timone University Hospital, Marseille, France. eric.guedj@ap-hm.fr.
3
CERIMED, Aix-Marseille Université, Marseille, France. eric.guedj@ap-hm.fr.
4
Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, F-54000, Nancy, France.
5
IADI, Université de Lorraine, INSERM U1254, F-54000, Nancy, France.
6
Aix-Marseille Université, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France.
7
Department of Nuclear Medicine, Assistance Publique des Hôpitaux de Marseille, Timone University Hospital, Marseille, France.
8
CERIMED, Aix-Marseille Université, Marseille, France.
PMID:
32303786
PMCID:
PMC7163172
DOI:
10.1007/s00259-020-04820-z
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections
Fluorodeoxyglucose F18*
Pandemics
Pneumonia, Viral
Positron Emission Tomography Computed Tomography
SARS-CoV-2
Substances
Fluorodeoxyglucose F18